Get started
Author

Michelle Jerry

Observed names: Jerry, Michelle, M. Jerry, MICHELLE JERRY, MS Michelle Jerry,
ORCID: 0000-0003-1664-8090
Observed ORCID: 0000-0003-1664-8090
OpenAlex ID: A5061451488
Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease
2023 · Michelle Jerry, Steve Arcona, et al. · ClinicoEconomics and Outcomes Research · 13
PDF
Work loss among privately insured employees with overweight and obesity in the United States
2024 · Shraddha Shinde, Anh Thu Tran, et al. · Obesity Science & Practice · 7
PDF
Impact of a Learning Collaborative Approach on Influenza and Pneumococcal Immunization Rates in US Adults: A Mixed Methods Approach
2019 · Elizabeth L. Ciemins, Michelle Jerry, et al. · Population Health Management · 7
An Adult Immunization Best Practices Learning Collaborative: Impact, Scale Up, and Spread
2020 · Elizabeth L. Ciemins, Michelle Jerry, et al. · Population Health Management · 6
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
2026 · Michelle Jerry, Divya Venkat, et al. · Frontiers in Public Health · 5
PDF
Direct and indirect costs for patients with myeloproliferative neoplasms
2024 · Jingbo Yu, James Nelson, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
2023 · Callisia N. Clarke, Paul Cockrum, et al. · Journal of health economics and outcomes research · 4
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US
2025 · Chuka Udeze, Michelle Jerry, et al. · Journal of Comparative Effectiveness Research · 3
PDF
Clinical and Economic Burden of Managing Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States
2025 · Chuka Udeze, Michelle Jerry, et al. · ClinicoEconomics and Outcomes Research · 3
PDF
Clinical burden and healthcare resource utilization after allogeneic hematopoietic stem cell transplant for sickle cell disease or β-thalassemia
2026 · Duncan Brown, Nanxin Li, et al. · Journal of Medical Economics · 1
PDF
Relationship between extended-release buprenorphine adherence and reduced risk of return to use in patients with opioid use disorder: A retrospective claims data analysis
2026 · Michelle Jerry, Divya Venkat, et al. · Drug and Alcohol Dependence Reports · 1
Clinical Outcomes and Complications in Patients with Beta-Thalassemia Who Received Allogeneic Hematopoietic Stem Cell Transplants in the United States
2025 · Duncan Brown, Nanxin Li, et al. · Transplantation and Cellular Therapy · 1
SAT657 Work Loss Among Privately Insured Employees With Overweight And Obesity In The United States
2023 · Shraddha Shinde, Michelle Jerry, et al. · Journal of the Endocrine Society · 1
PDF
MPN-531 Direct and Indirect Costs For Patients With Myeloproliferative Neoplasms (MPNs)
2023 · Jingbo Yu, Michelle Jerry, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Contemporary Economic, Hospitalization, and Mortality Burden Among Pulmonary Arterial Hypertension Patients: A Real‐World US Claims Data Analysis
2026 · Ashwin Ravichandran, Amélie Beaudet, et al. · Pulmonary Circulation
PDF
Disease Burden, Inadequate Hematocrit Control, and Thromboembolic Events in Patients with Polycythemia Vera Despite Current Standard of Care Treatment: A Retrospective Claims Study
2026 · Aaron T Gerds, Qi Fan, et al. · Journal of Blood Medicine
PDF
Ee295 Clinical and Economic Burden in Pediatric Patients With Transfusion-dependent Beta Thalassemia in the United States
2026 · JIAHE li, Arie Barlev, et al. · Value in Health
PDF
Ee401 Clinical and Economic Burden in Pediatric Patients With Sickle Cell Disease With Recurrent Vaso-occlusive Crises in the United States
2026 · JIAHE li, Arie Barlev, et al. · Value in Health
Clinical burden and healthcare resource utilization after allogeneic hematopoietic stem cell transplant for sickle cell disease or β-thalassemia
2026 · Brown, Duncan, Li, Nanxin, et al. · Figshare
The Long-Term Clinical Impact after Allogeneic Hematopoietic Stem Cell Transplants in Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises in the United States
2026 · Jiahe Li, Duncan Brown, et al. · Transplantation and Cellular Therapy
PT5 Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
2025 · Kimberly Le, Jonathan Scott Kurman, et al. · Value in Health
Supplementary data: Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US
2025 · Udeze, Chuka, Jerry, Michelle, et al. · Figshare
Work Productivity Burden Among Patients With Obstructive Sleep Apnea and Obesity Versus Controls Without Obstructive Sleep Apnea or Obesity
2025 · Oralee J. Varnado, Birong Liao, et al. · Journal of Occupational and Environmental Medicine
Burden of illness and hematocrit control among patients with high- and low-risk polycythemia vera receiving current standard of care treatment in the United States
2025 · Aaron Gerds, Angela (Qi) Fan, et al. · Blood
PDF
Pulmonary Nodule-related Health Care Resource Utilization After Diagnosis of Pulmonary Nodule in the United States
2025 · JONATHAN S KURMAN, KIMBERLY LE, et al. · CHEST Journal
Works count: 34
Citation count: 57
H-index: 5
I10-index: 1
Year
Topic
Type